NO20043008L - Fremgangsmate for behandling av bakterielle infeksjoner i hunder og katter - Google Patents

Fremgangsmate for behandling av bakterielle infeksjoner i hunder og katter

Info

Publication number
NO20043008L
NO20043008L NO20043008A NO20043008A NO20043008L NO 20043008 L NO20043008 L NO 20043008L NO 20043008 A NO20043008 A NO 20043008A NO 20043008 A NO20043008 A NO 20043008A NO 20043008 L NO20043008 L NO 20043008L
Authority
NO
Norway
Prior art keywords
cats
dogs
procedure
treatment
bacterial infections
Prior art date
Application number
NO20043008A
Other languages
English (en)
Inventor
Brian Scott Bronk
Simon Edward Blanchflower
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20043008L publication Critical patent/NO20043008L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO20043008A 2001-12-21 2004-07-15 Fremgangsmate for behandling av bakterielle infeksjoner i hunder og katter NO20043008L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26
PCT/IB2002/004741 WO2003053522A1 (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Publications (1)

Publication Number Publication Date
NO20043008L true NO20043008L (no) 2004-09-01

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043008A NO20043008L (no) 2001-12-21 2004-07-15 Fremgangsmate for behandling av bakterielle infeksjoner i hunder og katter

Country Status (12)

Country Link
EP (1) EP1455900A1 (no)
JP (1) JP2005524611A (no)
CN (1) CN1606463A (no)
AR (1) AR037594A1 (no)
AU (1) AU2002348985A1 (no)
BR (1) BR0215070A (no)
CA (1) CA2470995A1 (no)
IL (1) IL162103A0 (no)
NO (1) NO20043008L (no)
PL (1) PL370624A1 (no)
TW (1) TW200301126A (no)
WO (1) WO2003053522A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005002742T2 (de) * 2004-04-22 2008-01-24 Pfizer Products Inc., Groton Verfahren zur stabilisierung von ungeordnetem cefovecin-natriumsalz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
CA2470995A1 (en) 2003-07-03
IL162103A0 (en) 2005-11-20
JP2005524611A (ja) 2005-08-18
WO2003053522A1 (en) 2003-07-03
CN1606463A (zh) 2005-04-13
EP1455900A1 (en) 2004-09-15
AU2002348985A1 (en) 2003-07-09
AR037594A1 (es) 2004-11-17
TW200301126A (en) 2003-07-01
PL370624A1 (en) 2005-05-30
BR0215070A (pt) 2004-11-09

Similar Documents

Publication Publication Date Title
DK1448234T3 (da) Formuleringer, der omfatter en cephalosporinforbindelse, og deres anvendelse til behandling af bakterieinfektioner hos katte og hunde
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
NO20025204D0 (no) Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner
ZA200507857B (en) Compositions for treating microbial and parasitic infections in cattle and other animals
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
DK1239872T3 (da) Enzymbehandling til fordøjelseskanal-infektioner
EP1531828A4 (en) METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES
DE60036249D1 (de) Feldeffekttransistor und dessen Herstellungsverfahren
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
EP1389972A4 (en) ANIMAL PROCESSING AND MARKING SYSTEM
PT1227827E (pt) Bacterias acido-lacticas para o tratamento e/ou profilaxia da giardiase
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
HK1052643A1 (en) Use of pleuromutilin derivatives in the manufacture of a mediament for transdermal treatment of bacterial infections in humans and animals
NO20043008L (no) Fremgangsmate for behandling av bakterielle infeksjoner i hunder og katter
AU2003290506A8 (en) Methods and devices for treating severe peripheral bacterial infections
DE60336244D1 (de) Artikelbehandlungssystem und -verfahren
IL166122A0 (en) Methods of treating microbial infections in humansand animals
GB0323849D0 (en) Animal treatment system and method thereof
AU2003230853A1 (en) Method and systems for disinfecting animal bedding and stalls
AP2256A (en) Treatment of parasitic infections in humans and animals.
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
AU2002229446A1 (en) Hog farming process and barn
SE0302375D0 (sv) Method and device for treating microbial infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application